Concepedia

Federica Catalanotti

FC

13

Publications

1.5K

Citations

13

H-Index

2004

Active since

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Cornell University

University of Vienna

Max Perutz Labs

MolMed (Italy)

Federica Catalanotti is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, autoimmunity, and inflammation.

ORCID

Top concepts

Publications per year

2004–2018

13

Publications

13

HMGB1 is an endogenous immune adjuvant released by necrotic cells

Patrizia Rovere‐Querini, Annalisa Capobianco, Paola Scaffidi et al. · EMBO Reports · 2004 · 583 citations · Full text

, , +10

A Mek1–Mek2 heterodimer determines the strength and duration of the Erk signal

Federica Catalanotti, Gloria Reyes, Veronika Jesenberger et al. · Nature Structural & Molecular Biology · 2009 · 171 citations

, , +5

Phase II Trial of MEK Inhibitor Selumetinib (AZD6244, ARRY-142886) in Patients with BRAFV600E/K-Mutated Melanoma

Federica Catalanotti, David B. Solit, Melissa Pulitzer et al. · Clinical Cancer Research · 2013 · 138 citations · Full text

Clinical and Morphologic Characteristics of MEK Inhibitor–Associated Retinopathy

Jasmine H. Francis, Larissa A. Habib, David H. Abramson et al. · Ophthalmology · 2017 · 129 citations · Full text

, , +6

MEK1 Is Required for PTEN Membrane Recruitment, AKT Regulation, and the Maintenance of Peripheral Tolerance

Katarina Zmajkovicova, Veronika Jesenberger, Federica Catalanotti et al. · Molecular Cell · 2013 · 97 citations · Full text

Rows per page

1–5 of 13